NCT04089189 Study of IMP4297 in Patients With BRCA1/2 Mutation Ovarian Cancer Status COMPLETED Phase PHASE2
NCT04068896 Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy Status COMPLETED Phase PHASE1/PHASE2
NCT04068675 Effects of Centering Pre-operative Counseling on Patient Reported Anxiety Status COMPLETED Phase NA
NCT04055038 Efficacy of Platinum-based Chemotherapy in Platinum-resistant Ovarian Cancer) (EPITOC) Status UNKNOWN Phase PHASE2/PHASE3
NCT04053114 MOLecular Characterization and Treatment of THYroid Carcinoma on Struma Ovarii Status WITHDRAWN Phase N/A
NCT04051502 ICG-Enabled Mapping of Ovarian Sentinel Lymph Nodes: A Feasibility Study Status COMPLETED Phase EARLY_PHASE1
NCT04044859 ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS) Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT04041128 PARP Inhibition During Pre-surgical Window in Breast/Ovary Cancer Status COMPLETED Phase EARLY_PHASE1
NCT04038619 Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients Status RECRUITING Phase PHASE1
NCT04032600 Malignant Ascites in Ovarian Cancer: Impact of Total Paracentesis on Hemodynamics Status COMPLETED Phase NA
NCT04028479 The Registry of Oncology Outcomes Associated with Testing and Treatment Status COMPLETED Phase N/A
NCT04025216 A Study of CART-TnMUC1 in Patients With TnMUC1-Positive Advanced Cancers Status TERMINATED Phase PHASE1
NCT04024878 NeoVax With Nivolumab in Patients With Ovarian Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT04024254 A Study of Serum Folate Levels in Patients Treated With Olaparib Status COMPLETED Phase PHASE4
NCT04000295 Apatinib and Etoposide Capsule Versus Weekly Paclitaxel in Patients With Platinum Resistant Ovarian Cancer Status UNKNOWN Phase PHASE3
NCT03997968 A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT03992131 A Study to Evaluate Rucaparib in Combination With Other Anticancer Agents in Participants With a Solid Tumor (SEASTAR) Status TERMINATED Phase PHASE1/PHASE2
NCT03989336 A Study of the Pan-immunotherapy in Patients With Relapsed/Refractory Ovarian Cancer Status COMPLETED Phase PHASE2